Southridge Investment Group

Southridge Investment Group was a financial services firm and broker-dealer that specialized in providing capital to small-cap and micro-cap companies, with a significant emphasis on the biotechnology and life sciences sectors. Operating as a subsidiary of Southridge Capital Management, the firm was a prominent provider of Private Investment in Public Equity (PIPE) financing, often serving as a source of capital for early-stage healthcare ventures. While the firm facilitated the funding of numerous medical and pharmaceutical innovations, it did not conduct its own research and development or maintain a therapeutic pipeline. The company's operations have largely ceased following regulatory scrutiny and the termination of its broker-dealer registration with FINRA.